Neurodevelopment of Children Following Prenatal Exposure to Venlafaxine, Selective Serotonin Reuptake Inhibitors, or Untreated Maternal Depression
Irena Nulman, M.D.; Gideon Koren, M.D.; Joanne Rovet, Ph.D.; Maru Barrera, Ph.D.; Ariel Pulver, B.A.; David Streiner, Ph.D.; Brian Feldman, M.D.
From the Motherisk Program, Division of Clinical Pharmacology and Toxicology, Hospital for Sick Children, University of Toronto.
Am J Psychiatry 2012;169:1165-1174.
doi:10.1176/appi.ajp.2012.11111721
Purchase Online access to this article for 24 hours
Clicking on the buy now link will redirect you to the shopping cart at APPI.org where you will be asked to log in or create an account to complete your transaction. Once your transaction is complete, you will receive an email with instructions for accessing this content online and in PDF format.
You may view, download, and/or print the article for your personal, scholarly, research, and educational use. You may not (i) distribute a copy
(electronic or otherwise) of the article without the written permission of APA, (ii) post the article on an electronic bulletin board or web
site, or (iii) charge for a copy (electronic or otherwise) of the article.